Brief: Novabay Pharmaceuticals Engages Leading Chinese Marketing Firm To Drive Consumer Sales Of Dermadoctor Skincare Products In China
23/02/2022 13:49
Feb 23 (Reuters) - NovaBay Pharmaceuticals Inc NBY.A :
* NOVABAY PHARMACEUTICALS ENGAGES LEADING CHINESE MARKETING
FIRM
TO DRIVE CONSUMER SALES OF DERMADOCTOR SKINCARE PRODUCTS IN
CHINA
Source text for Eikon: ID:nBwbfsWcfa
Further company coverage: NBY.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stablecoin Development
See all newsBrief: Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing